D

Dyne Therapeutics
D

DYN

14.020
USD
0.01
(0.07%)
مغلق
حجم التداول
26,540
الربح لكل سهم
-4
العائد الربحي
-
P/E
-4
حجم السوق
1,426,758,731
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AEE
    AEE
    1.280
    (1.32%)
    98.520 USD
    DTE
    DTE
    0.800
    (0.61%)
    131.960 USD
    EIX
    EIX
    0.270
    (0.52%)
    52.170 USD
    EXC
    EXC
    0.205
    (0.47%)
    43.380 USD
    FE
    FE
    0.910
    (2.20%)
    42.290 USD
    PCG
    PCG
    0.290
    (1.85%)
    15.980 USD
    PPL
    PPL
    0.570
    (1.67%)
    34.730 USD
    SO
    SO
    0.595
    (0.68%)
    88.420 USD
    W
    WEC
    0.470
    (0.45%)
    104.030 USD
    XEL
    XEL
    0.680
    (0.98%)
    69.960 USD
    المزيد
الأخبار
المقالات

العنوان: Dyne Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both arein the ongoing phase 1/2 clinical trial.